Orexigen Therapeutics is a biopharmaceutical company that looks to be trading rather out of the spotlight. The company was co-founded Orexigen in 2002 by Eckard Weber, M.D, with Michael Cowley, Ph.D., to develop new weight loss medicines. This medicine was based on their novel discovery that the simultaneous stimulation of hypothalamic POMC (proopiomelanocortin) neural pathways … Continue reading “Orexigen Therapeutics, Inc. (NASDAQ: OREX) Co-Founder Has Left The Building”
